MedPath

Effect of ketogenic diet on patients with breast cancer

Not Applicable
Recruiting
Conditions
breast cancer.
Malignant neoplasm of breast of unspecified site, female
C50.91
Registration Number
IRCT20171105037259N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients with locally advanced and metastatic breast cancer (Stage III or IV) that will undergo chemotherapy for at least 3 months; Patients who accept ketogenic diet for 3 months; Between 18 -75 years old; BMI between 18.5 - 35.5; Karnofsky Performance Score more than 70%

Exclusion Criteria

Type I diabetes under Insulin therapy; Patients with liver, kidney or cardiac disease; Congenital metabolic disorders that impair Ketogenic diet such as Gluconeogenesis defect; Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete response rate. Timepoint: At the baseline and the end of the study. Method of measurement: clinical exam,lab test and imaging.
Secondary Outcome Measures
NameTimeMethod
Insulin level. Timepoint: 0, 45, 90. Method of measurement: Eliza.
© Copyright 2025. All Rights Reserved by MedPath